Published in Healthcare Finance, Tax and Law Weekly, July 5th, 2006
Alphatec has also granted the underwriters an option to purchase up to an additional 1,395,000 shares of common stock at the initial public offering price to cover over-allotments, if any. The common stock will trade on the NASDAQ National Market under the symbol "ATEC."
Net proceeds from the offering are expected to be approximately $71.4 million, or $83.1 million if the underwriters exercise their over-allotment option in full, after deducting the underwriting discounts and commissions and the estimated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.